Boehringer Ingelheim Investigational Site

München 81541

0 studies enrolling now · 5 studies all time

What they study most

Arthritis, Rheumatoid, Carcinoma, Non-Small-Cell Lung, HIV Infections, Myocardial Infarction, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients — Completed
• Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients — Completed
• Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC — Completed
• A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis — Completed
• A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI) — Stopped early